ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 11

Cartilage Tissue Engineering Using Collagen Scaffolds and Human Mesenchymal Stem Cells

Clara Sanjurjo-Rodriguez1, Adela Helvia Martinez-Sanchez1, Silvia Diaz-Prado2, Emma Muiños-Lopez1, Isaac M. Fuentes-Boquete2, Francisco J. De Toro2 and Francisco J. Blanco1, 1Osteoarticular and Aging Res. Lab. CIBER-BBN. Rheumatology Div. INIBIC-Complejo Hosp. Univ. A Coruña, A Coruña, Spain, 2Osteoarticular and Aging Res. Lab. CIBER-BBN. INIBIC- University of A Coruña, A Coruña, Spain

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: cartilage, Mesenchymal stem cells, osteoarthritis and tissue engineering

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Biology and Pathology of Bone and Joint

Session Type: Abstract Submissions (ACR)

 

 

Background/Purpose: The aim of this study was to obtain cartilage-like constructs by chondrogenic differentiation of   human bone marrow mesenchymal stem cells (hBM-MSCs) grown on different collagen scaffolds.

Methods: hBM-MSCs were characterized by flow cytometry using MSC markers and analysed for their multipotential differentiation capacity. These cells were cultured at a density of 200,000 cells/cm2 on different collagen scaffolds: Col I + Col II (C1C2); Col I + Col II + Heparan Sulfate (C1C2HS); Col I + Col II + Chondroitinsulfate (C1C2CHS); Col I + Heparin (C1OLH3). hBM-MSCs were cultured during 30 days in a chondrogenic differentiation medium supplemented with TGFβ-3. We have analysed cell growth and cell morphology by histochemical analysis and Transmission (TEM) and Scanning (SEM) Electron Microscope. Chondrogenic differentiation was confirmed by histochemical and immunohistochemical analysis. Moreover, we have tested relative gene expression of characteristic chondrocyte genes such us SOX9 and COLII. Finally, collagen concentration in the cultures supernatant was measured using a collagen Assay.

Results: hBM-MSCs were able to grow in the surface and inside of all the scaffolds and they were able to synthesize extracellular matrix (ECM) around the cells. Cellular proliferation was observed in all the scaffolds by PCNA (Proliferating Cell Nuclear Antigen) immunostaining, obtaining the highest values in C1C2 and in C1C2HS scaffolds. The percentage of cells, regarding the area of the analysed scaffold, was higher than 50% in C1C2 and C1OLH3 and higher than 75% in C1C2HS and C1C2CHS scaffolds. By means of immunostainings we detected Col II in the ECM of C1C2HS constructs and in the cytoplasm of the cells in C1C2 constructs. Collagen was detected in cultures supernatants of all the scaffolds obtaining the highest collagen release between 11-21 days of differentiation. These results indicated the beginning of the chondrogenic differentiation.  TEM showed that cells had large number of lipid vesicles, mitochondrias and high secretory activity. SEM allowed us to study the adherence of cells, morphology and the ECM. We have detected the expression of two markers of early chondrogenesis, SOX9 and COLII, in all the constructs at 30 days.

Conclusion: Our data showed that the best results were obtained with C1C2HS constructs. hBM-MSCs cultured in chondrogenic medium over these scaffolds were able to differentiate better into chondrocyte-like cells and to synthesize more ECM than over the other scaffolds. Resulting cartilage‑like constructs may be suitable candidates for Tissue Engineering. Acknowledgements: Opocrin S.P.A.; CIBER-BBN CB0-01-0040; SAI-UDC.

 

 

 

Figure: Image obtained from the different constructs by electron microscopy analysis and immunohistochemistry. Vertically in columns going from top to bottom are shown the different types of scaffolds and ordered in rows from left to right are shown the different analysis.


Disclosure:

C. Sanjurjo-Rodriguez,
None;

A. H. Martinez-Sanchez,
None;

S. Diaz-Prado,
None;

E. Muiños-Lopez,
None;

I. M. Fuentes-Boquete,
None;

F. J. De Toro,
None;

F. J. Blanco,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cartilage-tissue-engineering-using-collagen-scaffolds-and-human-mesenchymal-stem-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology